Breaking News

Experic Secures Growth Capital from 1315 Capital

Positions Experic to meet growing demand for advanced drug development, manufacturing, and clinical trial supply solutions.

Author Image

By: Charlie Sternberg

Associate Editor

Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the global biopharmaceutical industry, has announced a significant growth capital investment led by 1315 Capital, a Philadelphia-based, growth equity firm focused on healthcare, with participation from its existing investors including East Seattle Partners, Harro Höfliger Packaging Systems, Inc. and Kineticos Ventures.   The new capital injection will enable Experic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters